share_log
Moomoo 24/7 ·  Mar 6 11:51
Kura Oncology Shares Are Trading Higher After the Company Announced That It Dosed Its First Patient in Its Trial of KO-2806 Plus Cabozantinib in Renal Cell Carcinoma
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment